Genetic hypercoagulability: prevention suggests testing family members
Open Access
- 1 July 2001
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 98 (1), 21-22
- https://doi.org/10.1182/blood.v98.1.21
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic diseaseBritish Journal of Haematology, 2000
- Different Risks of Thrombosis in Four Coagulation Defects Associated With Inherited Thrombophilia: A Study of 150 FamiliesBlood, 1998
- The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous ThrombosisAnnals of Internal Medicine, 1998
- Factor V Leiden: should we screen oral contraceptive users and pregnant women?BMJ, 1996
- World distribution of factor V LeidenThe Lancet, 1995
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Mortality in hereditary antithrombin-III deficiency—1830 to 1989The Lancet, 1991